Liminal BioSciences Inc. LMNL

Short term cash is a problem unless they sell PRV ASAP

[stockbuphoon]

With this FDA ok and potential option execution by Kedrion, Kedrion can sell the PRV Ryplazim voucher. Market price is between 80M$-120M$ u.s., so lets say 100M$ u.s., LMNL get 70%.... 70M$ u.s. + 17M$ u.s. we cashed already, around 100M$ can$ , LMNL will be able to investigate their portfolio and create an IND, get it approved by the FDA after some time and then design a clinical study and then set up a clinical trial, recruit patients, hold the trial while buring over $5M a month (not including financing costs). Everything takes a lot of time with FDA. However, it may take Kedrion many months to find a buyer and LMNL has very little money in the bank right now per their Q1 report 21.6M on Mar 31, 2021 still burning $7-8M/month until they unload plasma division. I think that they are holding share price in place for financing immediately - after hours on a Friday is probably LMNL's style. 

Or you can believe Realstocky/Newcamo (same guy) who thinks that LMNL will be able to execute big time (based on history? LOL) and do more deals like this (sell or partner), we gat some in the oven already (which indication?). Doyour dd. Dont listen to the clown$ operating on this board. (Realstocky/Newcamo) They are here for your $$$... to sell their shares to you ...

[Newcamo]

This post has been removed in accordance with Community Policy

[GunnerG]

LOL, they made a deal to sell two collection facilities, Ryplazim (their only revenue) and sold 30% of the voucher for $22M. LMNL get 70% of the voucher when sold.  Should be about $70M coming from the voucher.  Thats a total of $92M. Had LMNL just sat on their hands and not made this dumb deal two weeks before FDA approval, they would have had $100M, kept the two collection facilities

[Newcamo]

This post has been removed in accordance with Community Policy

[GunnerG]

I know its US currency, all my numbers are USD.  Man you are slow, no matter which ID you use. So LMNL sold two weeks for $15M USD (two facilities), $5M USD (Ryplazim +) and will get $70M USD for voucher. $92M USD or $100M CDN as you like to chirp in with. Had they sat on their hands as I said.  They would have kept the two facilities, kept Ryplazim and the revenue stream AND had the